AIDS Research and Treatment / 2014 / Article / Tab 3

Research Article

Determinants of Mortality among Adult HIV-Infected Patients on Antiretroviral Therapy in a Rural Hospital in Southeastern Nigeria: A 5-Year Cohort Study

Table 3

Hazard ratios of mortality according to predictors for PLWHA in Nigerian Christian Hospital.

VariableUnadjusted (univariate)Adjusted (multivariate)
HR (95% CI)HR (95% CI)

Sex (female versus male)0.53 (0.34–0.83)<0.01
Age group (versus 15–24 years)
 25–34 years1.59 (0.21–12.06)0.651.25 (0.16–9.61)0.83
 35–44 years2.59 (0.35–18.96)1.89 (0.26–13.89)0.53
 45+ years4.9 (0.63–4.06)0.123.60 (0.49–26.56)0.21
Baseline CD4 staging (versus >500 cells)
 350–4990.65 (0.18–2.36)0.510.66 (0.18–2.40)0.53
 200–3490.82 (0.23–2.97)0.330.91 (0.25–3.30)0.88
 <2001.96 (2.03–7.74)<0.013.61 (1.84–7.07)<0.01
Drug combination
 Truvada versus Combivir 1st line2.36 (1.33–4.19)<0.011.88 (1.05–3.36)0.03
 Truvada versus Combivir 2nd line1.33 (1.36–0.19)0.781.36 (0.19–9.66)0.76

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.